ACM
XENT

Atika Capital Management’s Intersect ENT, Inc XENT Stock Holding History

Atika Capital Management’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-45,200
Closed -$1.29M – 79
2015
Q2 		$1.29M Buy
45,200
+7,200
+19% +$189K 0.58% 55
2015
Q1 		$982K Buy
+38,000
New +$869K 0.66% 54

Other funds holding XENT

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Atika Capital Management's XENT Position: Q3 2015 in Review

Atika Capital Management sold out of Intersect ENT, Inc (XENT) in Q3 2015, closing a stake of 45,200 shares — an estimated $1.29M sold.

Atika Capital Management first reported a position in XENT in Q1 2015 and held it in 2 quarters. The position peaked at $1.29M in Q2 2015. 125 funds tracked by Wall St. Rank hold XENT as of Q3 2015.

  • Atika Capital Management reported no remaining Intersect ENT, Inc position as of Q3 2015 after selling out during the quarter.
  • Atika Capital Management sold 45,200 Intersect ENT, Inc shares in Q3 2015, an estimated $1.29M.
  • Atika Capital Management first reported a position in Intersect ENT, Inc in Q1 2015 and held it in 2 quarters.
  • Atika Capital Management's Intersect ENT, Inc position peaked at $1.29M in Q2 2015.
  • 125 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2015.

Based on Atika Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.